BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3121844)

  • 21. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys.
    Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G
    Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A renal vasodilator effect of angiotensin II revealed by dual thromboxane inhibition.
    Badahman AH; Wilson TW
    Can J Physiol Pharmacol; 1994 Jun; 72(6):632-6. PubMed ID: 7954094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of renal vasoconstrictor effect of NG-nitro-L-arginine in rabbit by angiotensin II and alpha-1 adrenergic receptor blockade.
    Hajj-Ali AF; Reilly TM; Wong PC
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1152-7. PubMed ID: 7932165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
    Kontessis PS; Jones SL; Barrow SE; Stratton PD; Alessandrini P; De Cosmo S; Ritter JM; Viberti GC
    J Lab Clin Med; 1993 Mar; 121(3):415-23. PubMed ID: 8445289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulating role for thromboxane in the tubuloglomerular feedback response in the rat.
    Welch WJ; Wilcox CS
    J Clin Invest; 1988 Jun; 81(6):1843-9. PubMed ID: 2968365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection.
    Mangino MJ; Brunt EM; Von Doersten P; Anderson CB
    J Pharmacol Exp Ther; 1989 Jan; 248(1):23-8. PubMed ID: 2643702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboxane mediation of the pressor response to infused angiotensin II.
    Wilcox CS; Welch WJ
    Am J Hypertens; 1990 Mar; 3(3):242-9. PubMed ID: 2322437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboxane synthesis inhibition and renal allograft function.
    Anderson C; Jendrisak M; Brunt E; Tobimatsu M; Murphy M; Sicard G; Mangino M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1161-4. PubMed ID: 2650085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonsteroidal antiinflammatory drugs, prostaglandins, and the kidney.
    Rubin SI
    J Am Vet Med Assoc; 1986 May; 188(9):1065-8. PubMed ID: 3086264
    [No Abstract]   [Full Text] [Related]  

  • 30. Renal haemodynamics during hyperchloraemia in the anaesthetized dog: effects of captopril.
    Wilcox CS
    J Physiol; 1988 Dec; 406():27-34. PubMed ID: 3075984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Direct effects of prostaglandin E1 on renal blood flow and renal function during acute reduction of cardiac output in dogs].
    Tsuzaki K
    Masui; 1992 Jan; 41(1):25-32. PubMed ID: 1545498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromboxane receptor blockade improves cyclosporine nephrotoxicity in rats.
    Spurney RF; Mayros SD; Collins D; Ruiz P; Klotman PE; Coffman T
    Prostaglandins; 1990 Feb; 39(2):135-46. PubMed ID: 2138344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous prostaglandins modulate autoregulation of renal blood flow in young rats.
    Chevalier RL; Carey RM; Kaiser DL
    Am J Physiol; 1987 Jul; 253(1 Pt 2):F66-75. PubMed ID: 3037924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of renal nerve stimulation, norepinephrine and angiotensin II on renal blood flow in relation to release of PG-like substances in anesthetized dogs.
    Satoh S; Ohyama Y; Hayashi M
    Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):304-16. PubMed ID: 7337502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin and thromboxane in the enhanced renal adrenergic nerve sensitivity of acute renal failure.
    Robinette JB; Conger JD
    J Clin Invest; 1990 Nov; 86(5):1532-9. PubMed ID: 2243129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of thromboxane synthase inhibitors on renal function.
    Jackson EK; Goto F; Uderman HD; Workman RJ; Herzer WA; FitzGerald GA; Branch RA
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):183-90. PubMed ID: 3285227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of angiotensin II in the renal effects induced by nitric oxide and prostaglandin synthesis inhibition.
    Llinás MT; González JD; Nava E; Salazar FJ
    J Am Soc Nephrol; 1997 Apr; 8(4):543-50. PubMed ID: 10495783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of the nephrotoxicity of non-steroidal anti-inflammatory drugs.
    Dunn MJ; Scharschmidt L; Zambraski E
    Arch Toxicol Suppl; 1984; 7():328-37. PubMed ID: 6595999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of beta-adrenergic blockade and inhibitors of angiotensin II and prostaglandins on renal autoregulation.
    Anderson RJ; Taher MS; Cronin RE; McDonald KM; Schrier RW
    Am J Physiol; 1975 Sep; 229(3):731-6. PubMed ID: 813531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal hemodynamic effects of captopril in anesthetized sodium-restricted dogs. Relative contributions of prostaglandin stimulation and suppressed angiotensin activity.
    Carmines PK; Rosivall L; Till MF; Navar LG
    Ren Physiol; 1983; 6(6):281-7. PubMed ID: 6359304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.